Novacyt launches molecular HPV service to its NOVAPREP® customers

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics has launched a molecular HPV (Human Papillomavirus) service for all its customers who currently use its next generation NOVAprep® liquid-based cytology platform for cervical cancer screening. Download press release

Visit Page

Novacyt and Leica Biosystems launch NOVAPREP® in China

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics and Leica Biosystems, a leading supplier to the pathology market, today announce the start of the sales and marketing programme for the launch of the NOVAprep® platform in China. Download press release

Visit Page

Novacyt Full Year 2014 Results

Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, today announces its audited financial statement for the year ending 31st December, 2014,  approved by the Board of Directors on the 28th April 2015. Download press release

Visit Page